458 related articles for article (PubMed ID: 31567412)
1. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
Cillóniz C; Dominedò C; Torres A
Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
3. Incidence of ventilator-associated pneumonia and impact of multidrug-resistant infections on patient's outcome: Experience at an Apex Trauma Centre in North India.
Khurana S; Mathur P; Kumar S; Soni KD; Aggrawal R; Batra P; Bhardwaj N
Indian J Med Microbiol; 2017; 35(4):504-510. PubMed ID: 29405141
[TBL] [Abstract][Full Text] [Related]
4. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
5. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
[TBL] [Abstract][Full Text] [Related]
6. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
[TBL] [Abstract][Full Text] [Related]
8. Management of ventilator-associated pneumonia (VAP) caused by resistant gram-negative bacteria: which is the best strategy to treat?
Sarda C; Fazal F; Rello J
Expert Rev Respir Med; 2019 Aug; 13(8):787-798. PubMed ID: 31210549
[No Abstract] [Full Text] [Related]
9. How to treat VAP due to MDR pathogens in ICU patients.
Garnacho-Montero J; Corcia-Palomo Y; Amaya-Villar R; Martin-Villen L
BMC Infect Dis; 2014 Nov; 14():135. PubMed ID: 25430700
[TBL] [Abstract][Full Text] [Related]
10. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.
Behnia M; Logan SC; Fallen L; Catalano P
BMC Res Notes; 2014 Apr; 7():232. PubMed ID: 24725655
[TBL] [Abstract][Full Text] [Related]
12. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
Martin-Loeches I; Rodriguez AH; Torres A
Curr Opin Crit Care; 2018 Oct; 24(5):347-352. PubMed ID: 30063491
[TBL] [Abstract][Full Text] [Related]
13. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
Gu WJ; Wang F; Tang L; Bakker J; Liu JC
Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
[TBL] [Abstract][Full Text] [Related]
14. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
15. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
[TBL] [Abstract][Full Text] [Related]
16. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
17. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.
Bassetti M; Taramasso L; Giacobbe DR; Pelosi P
Expert Rev Anti Infect Ther; 2012 May; 10(5):585-96. PubMed ID: 22702322
[TBL] [Abstract][Full Text] [Related]
18. Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection.
Papadomichelakis E; Kontopidou F; Antoniadou A; Poulakou G; Koratzanis E; Kopterides P; Mavrou I; Armaganidis A; Giamarellou H
Intensive Care Med; 2008 Dec; 34(12):2169-75. PubMed ID: 18712349
[TBL] [Abstract][Full Text] [Related]
19. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
Bhadade R; Harde M; deSouza R; More A; Bharmal R
Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
Trials; 2015 Mar; 16():102. PubMed ID: 25872790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]